Cargando…
Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries
BACKGROUND: Many people living with chronic HBV infection remain undiagnosed until later stages of disease. Increasing testing and treatment rates form part of the strategy to respond to the WHO goal of eliminating viral hepatitis as a public health threat by 2030. However, achieving these ambitious...
Autores principales: | Nayagam, Shevanthi, Sicuri, Elisa, Lemoine, Maud, Easterbrook, Philippa, Conteh, Lesong, Hallett, Timothy B., Thursz, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688395/ https://www.ncbi.nlm.nih.gov/pubmed/29143675 http://dx.doi.org/10.1186/s12879-017-2778-x |
Ejemplares similares
-
Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia
por: Schmit, Nora, et al.
Publicado: (2023) -
The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups
por: Schmit, Nora, et al.
Publicado: (2020) -
Economic evaluation of HCV testing approaches in low and middle income countries
por: Morgan, Jake R., et al.
Publicado: (2017) -
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
por: Heffernan, Alastair, et al.
Publicado: (2019) -
Using Economic Evidence to Set Healthcare Priorities in Low‐Income and Lower‐Middle‐Income Countries: A Systematic Review of Methodological Frameworks
por: Wiseman, Virginia, et al.
Publicado: (2016)